Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹10,233 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹10,233 Cr
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr
Mar2021₹-7.81 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹10,233 Cr
194,066.22
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr
Positive
Mar2021 ₹-7.81 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,018.2 Cr -0.4% -10.9% -16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.4%

-10.9%

-16.1%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses